WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001031013) HUMAN GOLD-INDUCED GLYCOPROTEIN 30-LIKE PROTEIN AND NUCLEIC ACID ENCODING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/031013 International Application No.: PCT/US2000/029559
Publication Date: 03.05.2001 International Filing Date: 27.10.2000
Chapter 2 Demand Filed: 17.05.2001
IPC:
A61K 38/00 (2006.01) ,C07K 14/47 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
46
from vertebrates
47
from mammals
Applicants: LEWIN, David, A.[US/US]; US (UsOnly)
STEWART, Timothy, A.[US/US]; US (UsOnly)
CURAGEN CORPORATION[US/US]; 11th Floor 555 Long Wharf Drive New Haven, CT 06511, US (AllExceptUS)
Inventors: LEWIN, David, A.; US
STEWART, Timothy, A.; US
Agent: RAUCH, Paul, E.; Brinks Hofer Gilson & Lione P.O. Box 10087 Chicago, IL 60610, US
Priority Data:
09/698,36926.10.2000US
60/161,97828.10.1999US
Title (EN) HUMAN GOLD-INDUCED GLYCOPROTEIN 30-LIKE PROTEIN AND NUCLEIC ACID ENCODING THE SAME
(FR) PROTEINE HUMAINE DE TYPE GLYCOPROTEINE 30 INDUITE PAR LE FROID ET ACIDES NUCLEIQUES CODANT POUR CELLE-CI
Abstract:
(EN) The invention provides a novel human cold-induced glycoprotein-30-like protein (hCig30L protein) and isolated nucleic acid molecules encoding the same. Also provided are antibodies that immunospecifically-bind to hCig30L polypeptide or polynucleotide, or derivatives, variants, mutants, or fragments thereof. The invention additionally provides methods in which the hCig30L polypeptide, polynucleotide, and antibody are used in the detection, prevention, and treatment of a broad range of pathological states, and methods of treating obesity-related disorders or modulating thermogenesis by modulating activity or expression of hCig30L protein.
(FR) L'invention concerne une nouvelle protéine humaine de type glycoprotéine 30 induite par le froid (protéine hCig30L), ainsi que des molécules d'acides nucléiques isolées codant pour celle-ci. L'invention concerne également des antibiotiques liant de manière immunospécifique le polypeptide ou le polynucléotide hCig30L, ou leurs dérivés, variants, mutants ou fragments. L'invention concerne en outre des techniques dans lesquelles on utilise le polypeptide, le polynucléotide et l'anticorps hCig30L dans la détection, la prévention et le traitement de nombreux états pathologiques, ainsi que des techniques permettant de traiter les troubles liés à l'obésité ou de moduler la thermogenèse par la modulation de l'activité ou de l'expression de la protéine hCig30L.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)